Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Read More
Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
Read More
Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
Learn More
Webinar: Protein Conformational Analysis Goes High-Throughput with xMAP Technology
Technique provides critical data for development of monoclonal antibodies and biosimilars
At a 2018 xMAP® Connect user group meeting, Xing Wang, President of Array Bridge, spoke about how his team is using xMAP Technology to streamline the development of new biologics and biosimilars for pharma/biotech scientists. The 30-minute presentation focuses on protein conformational analysis (PCA), a multiplex approach that replaces previous testing performed with ELISAs.
Continue Reading >
ARVE Error: id and provider shortcodes attributes are mandatory for old shortcodes. It is recommended to switch to new shortcodes that need only url
xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.
Watch more videos >
September 26
Luminex Corporation to Present at the Cantor Global Healthcare Conference on
October 2, 2019
3 September
Luminex Corporation to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
31 July
Luminex Corporation Reports Second Quarter 2019 Financial Results And Increase In Quarterly Dividend
11 July
Luminex Corporation Second Quarter Earnings Release Scheduled for July 31, 2019
